Novo Nordisk to pump $2bn into diabetes network on back of oral GLP-1 milestone

Novo Nordisk headquarters in Bagsværd, Denmark

Novo Nordisk could spend up to $2bn (€1.8bn) on two facilities to support its diabetes portfolio, including an oral long-acting GLP-1 analogue set to enter Phase III trials.

Red glow from the microfish demonstrates the detoxification process. (Image: W. Zhu and J. Li, UC San Diego Jacobs School of Engineering)

Scientists build ‘microfish’ robots for controlled drug delivery

Online customers are prey to fake pharmacies, says MHRA

MHRA uncovers $1m illegal ED drug haul

Novo opts to build US API capacity for semaglutide rather than outsource

To supply the Dane: Novo expects First API batch in 2020

Allergan has begun a voluntary recall of several eye treatments

Europe, US, Japan: The recall round-up

Generics firms were among the attendees at CPhI Japan in April

MHLW urges Japan's generics sector to consolidate

Inhalation formulation testing expert John Baxter at Intertek

Device advice: Intertek study shows its key to consider devices in formulation development

See More Headlines

Regulatory & Safety

MHRA says incorrect fee payments are holding up applications

MHRA launches fees calculator

US Patent and Trademark Office (USPTO) headquarters in Virgina (Image: Alan Kotok)

‘Sheer ridiculousness’ or fair play? USPTO turns down patent challenge

US FTC gives Pfizer the thumbs up for Hospira deal

Pfizer’s $17bn Hospira deal set to close in September after US FTC clearance

See More in Regulatory & Safety


Dynamite for cancer treatment? Nitroglycerin can improve chemotherapy say researchers

Cure not kill: Dynamite ingredient can improve cancer treatment says study

DSM HQ in Heerlen

DSM says plans to cut 1,100 jobs prompted by recent pharma moves not shareholder pressure

AmbioPharma expands US manufacturing site and starts work on global HQ

AmbioPharma expands US manufacturing site and starts work on global HQ

See More in Ingredients

Drug Delivery

Google launches life sci unit as standalone firm

Google launches life sci unit as standalone Alphabet company

Unilife whistleblower retracts allegations

Unilife whistleblower case blows over; Ex-exec apologises

The controlled delivery tech is based on molecules which attract and repel water in APIs

European firms form JV for protein delivery polymers

See More in Drug Delivery


Construction will begin later this year

GSK backtracks on Memphis divestment plans, invests $2m

Regis employees received training in handling dangerous chemicals

CMO Regis Technologies opens potent API site

Mylan determined to acquire Perrigo in generics sector

‘Eat or be eaten;’ Mylan says Perrigo could be run as subsidiary

See More in Processing

Popular News

A fireball from a series of blasts in Tianjin, northern China

Tianjin explosions hit GSK pharma production site

Three Mylan plants in India hit with FDA warning letter

Three Mylan plants in India hit with FDA warning letter

Merck & Co. is planning thousands more manufacturing job cuts

Merck & Co. plans over 2,500 manufacturing job cuts




Latest Products

See more products